Olink

Olink®
Part of Thermo Fisher Scientific

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS

Clinical and Translational Medicine, 2022

García‐Hidalgo M., González J., Benítez I., Carmona P., Santisteve S., Moncusí‐Moix A., Gort‐Paniello C., Rodríguez‐Jara F., Molinero M., Perez‐Pons M., Torres G., Caballero J., Barberà C., Tedim A., Almansa R., Ceccato A., Fernández‐Barat L., Ferrer R., Garcia‐Gasulla D., Menéndez R., Motos A., Peñuelas O., Riera J., Bermejo‐Martin J., Torres A., Barbé F., de Gonzalo‐Calvo D.,

Disease areaApplication areaSample typeProducts
Infectious Diseases
Pathophysiology
Plasma
O

Olink Target 96

Abstract

No abstract (letter to editor format).

Read publication ↗